Brown Brothers Harriman & CO Nex Immune, Inc. Transaction History

Brown Brothers Harriman & CO

  • $12.7 Billion
  • Q2 2024

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 13, 2022
BUY
$1.79 - $4.65 $219,955 - $571,392
122,880 New
122,880 $517,000

About NexImmune, Inc.

NEXI Quotes by TradingView
  • Ticker NEXI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 24,155,600
  • Market Cap $6.04M
  • Description
  • NexImmune, Inc., a clinical-stage biotechnology company, engages in developing therapies with curative potential for patients with cancer and other life-threatening immune-mediated diseases. It develops approaches to T cell immunotherapies based on its proprietary Artificial Immune Modulation, a nanoparticle technology platform. The company's pr...
More about NEXI
Track This Portfolio

Track Brown Brothers Harriman & CO Portfolio

Follow Brown Brothers Harriman & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Brown Brothers Harriman & CO, based on Form 13F filings with the SEC.

News

Stay updated on Brown Brothers Harriman & CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email